Treatment sequencing for simultaneous colorectal liver metastases

Journal of Surgical Oncology
Robert W Krell, Michael I D'Angelica

Abstract

Up to 25% of patients with colorectal cancer present with simultaneous metastases and the liver is frequently the only metastatic site. This review will review treatment sequence planning considerations-including metastatic burden, primary tumor site, chemotherapy response, and ability to perform minimally invasive surgery-for patients with simultaneous resectable colorectal liver metastases. In addition, this review will address conversion chemotherapy, combined vs staged surgeries, and their possible sequences.

References

Sep 28, 2000·The New England Journal of Medicine·L B SaltzL L Miller
Aug 2, 2003·Journal of the American College of Surgeons·Robert MartinLeslie Blumgart
May 14, 2004·The New England Journal of Medicine·UNKNOWN Clinical Outcomes of Surgical Therapy Study GroupDavid Ota
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Nicolas VautheyEddie K Abdalla
Jul 22, 2006·Annals of Surgery·Sylvain ManfrediAnne-Marie Bouvier
Sep 7, 2006·Annals of Surgical Oncology·Eddie K AbdallaDavid Mahvi
Oct 30, 2007·Journal of the American College of Surgeons·Shimul A ShahSteven Gallinger
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
May 2, 2008·Journal of Surgical Oncology·Rebekah R WhiteNancy E Kemeny
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten BokemeyerPiotr Koralewski
Mar 6, 2009·The Lancet Oncology·Yun Shin ChunJean-Nicolas Vauthey
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott KopetzRobert R McWilliams
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy E KemenyMichael D'Angelica
May 30, 2009·Journal of the American College of Surgeons·Robert C G MartinKelly M McMasters
Jun 1, 2010·Journal of the American College of Surgeons·Antoine BrouquetEddie K Abdalla
Jun 26, 2010·The British Journal of Surgery·R J de HaasD Castaing
Oct 26, 2010·Critical Reviews in Oncology/hematology·Derek G Power, Nancy E Kemeny
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carlo AscheleLuca Boni
Sep 29, 2011·World Journal of Surgery·Luca ViganòLorenzo Capussotti
Sep 11, 2012·The Oncologist·René AdamUNKNOWN Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group
Feb 26, 2013·Journal of the American College of Surgeons·Skye C MayoTimothy M Pawlik

❮ Previous
Next ❯

Citations

Feb 27, 2019·Journal of Surgical Oncology·Laleh G Melstrom, Ching-Wei D Tzeng
Jul 27, 2021·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Myrtle F KrulUNKNOWN Dutch Hepato Biliary Audit Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.